molnupiravir – FDA’s Antimicrobial Drugs Advisory Committee Review
November 30, 2021 - The FDA’s Antimicrobial Drugs Advisory Committee (AMDAC) met to discuss the emergency use authorization (EUA) application for molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 including hospitalization or death.
Top